Patients who use Apretude (cabotegravir) extended-release injection must complete an oral lead-in…

Written by

in

Patients who use Apretude (cabotegravir) extended-release injection must complete an oral lead-in with cabotegravir to ensure medication tolerance according to the FDA label.TrueFalse

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *